Telescope Innovations Corp. (CSE: TELI)

Market Cap	21.48M
Revenue (ttm)	4.43M
Net Income (ttm)	-1.32M
Shares Out	53.70M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,343
Average Volume	16,373
Open	0.400
Previous Close	0.400
Day's Range	0.400 - 0.400
52-Week Range	0.210 - 0.550
Beta	1.50
RSI	61.61
Earnings Date	Jan 27, 2025

About Telescope Innovations

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. The company has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. is based in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Henry Dubina
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TELI

Financial Performance

In 2024, Telescope Innovations's revenue was 4.43 million, an increase of 56.80% compared to the previous year's 2.82 million. Losses were -1.32 million, 84.3% more than in 2023.